Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PTHS compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
PTHS
Pelthos Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
PTHS
Pelthos Therapeutics Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PTHS, solid
AMGN, dashed
PTHS
Pelthos Therapeutics Inc.
Change
11.38
▲
+5.52%
· post 10.14
· delayed
Mkt cap
$41.3M
Revenue
$16M
Q2 FY26
Revenue
—
AMGN
Amgen Inc
Change
460.67
▼
−0.13%
· post 478.34
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$249.4B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
After hours
Nov 4 '26
delayed
PTHS
Pelthos Therapeutics Inc.
vs
AMGN
Amgen Inc
11.38
▲
+5.52%
post 10.14
delayed
Price
460.67
▼
−0.13%
post 478.34
delayed
$41.3M
Mkt cap
$249.4B
Q2 FY26
$16M
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
PTHS
11.38
▲
+5.52%
vs
AMGN
460.67
▼
−0.13%
After hours
Nov 4 '26
delayed